Status: Not yet recruiting
Matched Sibling Allogenic Stem Cell Transplantation With Adoptive Immunotherapy With Regulatory And Conventional T Cells For High Risk Acute Myeloid Leukemia
The study is a multicentric, interventional study that evaluates the efficacy of allogeneic HLA-matched allo-HSCT consisting of myeloablative conditioning coupled with donor Treg/Tcon adoptive immunotherapy for high-risk AML patients.
Participants needed: 28
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Antonio PieriniUpdated: Apr 27, 2026Locations: 2
Eligibility criteria
Diagnosis of AML with adverse genetic mutations in Complete Remission (CR) or in... [+7]
Prior allo-HSCT [+10]